Does age affect the response to zinc therapy for diarrhoea in Bangladeshi infants?
- PMID: 18637534
- PMCID: PMC2740681
Does age affect the response to zinc therapy for diarrhoea in Bangladeshi infants?
Abstract
The benefit of zinc for the treatment of diarrhoea in a cluster-randomized trial of children, aged 3-59 months, living in rural Bangladesh was previously reported. Here, the benefits of zinc stratified by age--3-5 months, 6-11 months, and 12-59 months--are reported. Although the sample sizes in the stratified groups were too small to detect statistical significance in the 3-5-month and 6-11-month age-groups, the trends suggest that there may be a benefit of zinc for the treatment of diarrhoea on the duration of diarrhoea and on subsequent morbidity and mortality. Additional research is needed to better understand the effect of zinc for the treatment of diarrhoea among infants aged less than six months.
References
-
- In: Trace elements in human nutrition and health. Geneva: World Health Organization; 1996. World Health Organization. Zinc; pp. 72–104.
-
- Zinc Investigators’ Collaborative Group. Therapeutic effects of oral zinc in acute and persistent diarrhea in children in developing countries: pooled analysis of randomized controlled trials. Am J Clin Nutr. 2000;72:1516–22. - PubMed
-
- Zinc Investigators’ Collaborative Group. Prevention of diarrhea and pneumonia by zinc supplementation in children in developing countries: pooled analysis of randomized controlled trials. Zinc Investigators’ Collaborative Group. J Pediatr. 1999;135:689–97. - PubMed
-
- WHO-UNICEF joint statement on the clinical management of acute diarrhoea. Geneva: World Health Assembly; 2004. World Health Organization; pp. 1–8.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical